The stock of Cellect Biotechnology Ltd. (NASDAQ:APOP) is now priced at $3.18 and the shares are -0.04 points down or -1.24% lower compared to its previous closing price of $3.22. The stock had 34647 contracts set over the past session. APOP shares’ daily volume is compared to its average trading volume at 1.123 million shares. However, it has a float of 2.22 million and although its performance was -2.13% over the week, it’s one to watch. APOP share price recently placing at $3.18 to $3.2801. However, some brokerage firms have priced the stock below the average, including one that has called $3.
The shorts are running away from the Cellect Biotechnology Ltd. stock, with the latest data on short interest released on June 15, 2020, showing that short interest numbers in the APOP shares have declined. Short interest in the stock represents just 2.07% of its float, but the volume has dropped by -21205. The volume of shorted shares dropped to 46039 from 67244 shares over the last two weeks. The average intraday trading volume has been 146026 shares, which means that days to cover moved to roughly 1.
In the last trading session, Cellect Biotechnology Ltd. (NASDAQ:APOP) raised by $0.03 over the week and lost -$0.04 on its 20-day. The stock’s high in the recent session is lower when compared to its 52-week high of $6.89. The stock recorded its established 52-week high on 01/07/20.
Since 03/12/20, the stock has traded to a low of $0.4 at 695%, an encouraging piece of data likely to interest most investors out to exploit the stock’s recent surge.
Looking at current readings, Cellect Biotechnology Ltd.’s two-week RSI is 53.75. This suggests that the stock is neutral at the moment and that APOP shares’ price movement remains stable. The stochastic readings are equally revealing at 29.16% meaning the APOP share price is currently in overbought territory.
The technical chart shows that the APOP stock will likely settle at between $3.27 and $3.33 per share. However, if the stock dips below $3.17, then its market would become much weaker. Any downside could see the stock price sliding to levels as low as $3.13.
Analysts at H.C. Wainwright though raised target price of APOP stock from $12 to $14 but maintained Buy recommendation in their September 25 review.